本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Lyra Therapeutics

0.0991
+0.00657.02%
成交量:149.91万
成交额:14.73万
市值:652.87万
市盈率:-0.07
高:0.1031
开:0.0922
低:0.0914
收:0.0926
数据加载中...
2024/04/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/30

重要事件披露

Form 8-K - Current report
2024/04/19

重要事件披露

Form 8-K - Current report
2024/03/28

SEC问询函

Form CORRESP - Correspondence
2024/03/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/22

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/21

重要事件披露

Form 8-K - Current report
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/28

重要事件披露

Form 8-K - Current report
2023/12/19

重要事件披露

Form 8-K - Current report
2023/11/17

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/07

重要事件披露

Form 8-K - Current report
2023/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]